Versailles, France

Francois-Xavier Jarreau



Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • Paris, FR (1977)
  • Versailles, FR (1980 - 1989)

Company Filing History:


Years Active: 1977-1989

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Francois-Xavier Jarreau

Introduction

Francois-Xavier Jarreau, a renowned inventor based in Versailles, France, has made significant contributions to the field of pharmaceutical innovations. With a total of eight patents to his name, his work primarily focuses on advancements in therapeutic agents, particularly those related to cardiac health.

Latest Patents

Among his notable inventions are two recent patents that stand out in the realm of medicinal chemistry. The first involves novel 14-amino steroids, which are linked to the treatment of heart failure. This invention centers around androstane-17-carboxylic acid esters, represented by a complex chemical formula that outlines various substituents tailored for therapeutic efficacy. The preparation of these esters is achieved through a coupling reaction involving 14-azido derivatives with sugars, culminating in a reduction process.

The second patent focuses on antiarrhythmic quinidine derivatives that are designed to treat cardiac arrhythmia. These derivatives are characterized by a formula that allows for versatile modifications, including hydrogen, alkyl, and acyl groups, along with various hydroxy and alkoxy variants. The therapeutic implications of these compounds aim to provide effective solutions for patients experiencing cardiac rhythm disturbances.

Career Highlights

Throughout his career, Francois-Xavier Jarreau has showcased his ingenuity and dedication to advancing medical science. He has held key positions at esteemed organizations such as Etablissements Nativelle and Norwich Eaton Pharmaceuticals, Inc. His research initiatives have contributed significantly to enhancing treatment methodologies for heart-related ailments.

Collaborations

Francois-Xavier Jarreau has collaborated with outstanding professionals in his field, including Jean-Jacques Koenig and Jean J Koenig. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and expertise that drive advancements in pharmaceutical research.

Conclusion

Francois-Xavier Jarreau's contributions demonstrate a profound impact on medical therapies, particularly in the treatment of cardiovascular conditions. His patented inventions reflect a commitment to improving patient outcomes and exemplify the essence of innovation in the pharmaceutical industry. As research continues to evolve, his work remains a testament to the significance of creativity and collaboration in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…